Medicinal Cannabis: Evolution of Therapeutic Use, Future Approaches and Other Implications, Volume II

Medicinal Cannabis: Evolution of Therapeutic Use, Future Approaches and Other Implications, Volume II PDF Author: Paola Brusa
Publisher: Frontiers Media SA
ISBN: 2832540171
Category : Medical
Languages : en
Pages : 129

Get Book Here

Book Description
This Research Topic is the second volume of its kind. Please see the publications of the first collection here. Cannabis has been used in even the oldest traditional medicines available. In the last century, somewhat negative attention has prevailed when it comes to the psychotropic and addictive effects and abuse potential; for this reason Cannabis has been banned and is illegal in many countries. In recent years, however, there has been a more in-depth evaluation of the legalization of cannabinoids for medical use in several countries following heightened media attention and reports of effectiveness, although not always thoroughly backed up by scientific evidence. In fact, up to now the results from studies discussing the efficacy of the medical use of Cannabis are sometimes contradictory and not always conclusive. Some factors fueling this inconclusiveness include the heterogeneous nature of the studied populations, different Cannabis preparations and dosages, studies with uncontrolled settings and different routes of administration. Moreover, these uncertainties are partly derived from legislative restrictions which, over time, have severely limited the conduction of rigorous, controlled, and comparable studies. The official introduction of pharmaceutical grade Cannabis inflorescences for medicinal purposes has allowed physicians and pharmacists respectively to legally prescribe and prepare several Cannabis preparations. Such products are currently being administered to patients without their efficacy being evaluated in controlled studies: for each patient the composition and route of administration may be different. In addition, many advanced administration systems have been developed or are still under development, but few clinical trials have been completed. This second volume welcomes submissions of Original Research and Review articles building on and focusing on the in-depth analysis of the legal, technological and pharmacological aspects related to the medical use of chemically characterized Cannabis-based formulations. Studies carried out in the past or still in progress will also be considered to assess what evolution there has been in using Cannabis to treat diseases or conditions. We invite submissions dealing with the following themes, including but not limited to: • Cannabis-based formulations: current and future applications in therapy. • Legal, technological, and pharmacological aspects related to the medical use of Cannabis. • Non-clinical evidence supporting therapeutic applications of Cannabis (including in vivo, in invitro and in silico studies) Important note for Authors : Only studies dealing with highly purified, chemically characterized Cannabis containing formulations, where the chemical structure and purity must be precisely described by appropriate analytical methods will be considered for review in Experimental Pharmacology and Drug Discovery. The following studies can be accepted for review in Ethnopharmacology if the extract is characterised in sufficient detail as is needed for a licensed medicine (see here.) (I) Clinical Trial articles will be accepted for review only in the case that they are randomized, double-blinded, and placebo controlled. (II) Any studies relating to advanced formulations or galenic preparations to better evaluate the potential effects of their application in future therapies.

Medicinal Cannabis: Evolution of Therapeutic Use, Future Approaches and Other Implications, Volume II

Medicinal Cannabis: Evolution of Therapeutic Use, Future Approaches and Other Implications, Volume II PDF Author: Paola Brusa
Publisher: Frontiers Media SA
ISBN: 2832540171
Category : Medical
Languages : en
Pages : 129

Get Book Here

Book Description
This Research Topic is the second volume of its kind. Please see the publications of the first collection here. Cannabis has been used in even the oldest traditional medicines available. In the last century, somewhat negative attention has prevailed when it comes to the psychotropic and addictive effects and abuse potential; for this reason Cannabis has been banned and is illegal in many countries. In recent years, however, there has been a more in-depth evaluation of the legalization of cannabinoids for medical use in several countries following heightened media attention and reports of effectiveness, although not always thoroughly backed up by scientific evidence. In fact, up to now the results from studies discussing the efficacy of the medical use of Cannabis are sometimes contradictory and not always conclusive. Some factors fueling this inconclusiveness include the heterogeneous nature of the studied populations, different Cannabis preparations and dosages, studies with uncontrolled settings and different routes of administration. Moreover, these uncertainties are partly derived from legislative restrictions which, over time, have severely limited the conduction of rigorous, controlled, and comparable studies. The official introduction of pharmaceutical grade Cannabis inflorescences for medicinal purposes has allowed physicians and pharmacists respectively to legally prescribe and prepare several Cannabis preparations. Such products are currently being administered to patients without their efficacy being evaluated in controlled studies: for each patient the composition and route of administration may be different. In addition, many advanced administration systems have been developed or are still under development, but few clinical trials have been completed. This second volume welcomes submissions of Original Research and Review articles building on and focusing on the in-depth analysis of the legal, technological and pharmacological aspects related to the medical use of chemically characterized Cannabis-based formulations. Studies carried out in the past or still in progress will also be considered to assess what evolution there has been in using Cannabis to treat diseases or conditions. We invite submissions dealing with the following themes, including but not limited to: • Cannabis-based formulations: current and future applications in therapy. • Legal, technological, and pharmacological aspects related to the medical use of Cannabis. • Non-clinical evidence supporting therapeutic applications of Cannabis (including in vivo, in invitro and in silico studies) Important note for Authors : Only studies dealing with highly purified, chemically characterized Cannabis containing formulations, where the chemical structure and purity must be precisely described by appropriate analytical methods will be considered for review in Experimental Pharmacology and Drug Discovery. The following studies can be accepted for review in Ethnopharmacology if the extract is characterised in sufficient detail as is needed for a licensed medicine (see here.) (I) Clinical Trial articles will be accepted for review only in the case that they are randomized, double-blinded, and placebo controlled. (II) Any studies relating to advanced formulations or galenic preparations to better evaluate the potential effects of their application in future therapies.

Medicinal Cannabis: Evolution of Therapeutic Use, Future Approaches and Other Implications

Medicinal Cannabis: Evolution of Therapeutic Use, Future Approaches and Other Implications PDF Author: Paola Brusa
Publisher: Frontiers Media SA
ISBN: 283250163X
Category : Science
Languages : en
Pages : 150

Get Book Here

Book Description


The Health Effects of Cannabis and Cannabinoids

The Health Effects of Cannabis and Cannabinoids PDF Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309453070
Category : Science
Languages : en
Pages : 487

Get Book Here

Book Description
Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

Marijuana As Medicine?

Marijuana As Medicine? PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309065313
Category : Medical
Languages : en
Pages : 216

Get Book Here

Book Description
Some people suffer from chronic, debilitating disorders for which no conventional treatment brings relief. Can marijuana ease their symptoms? Would it be breaking the law to turn to marijuana as a medication? There are few sources of objective, scientifically sound advice for people in this situation. Most books about marijuana and medicine attempt to promote the views of advocates or opponents. To fill the gap between these extremes, authors Alison Mack and Janet Joy have extracted critical findings from a recent Institute of Medicine study on this important issue, interpreting them for a general audience. Marijuana As Medicine? provides patientsâ€"as well as the people who care for themâ€"with a foundation for making decisions about their own health care. This empowering volume examines several key points, including: Whether marijuana can relieve a variety of symptoms, including pain, muscle spasticity, nausea, and appetite loss. The dangers of smoking marijuana, as well as the effects of its active chemical components on the immune system and on psychological health. The potential use of marijuana-based medications on symptoms of AIDS, cancer, multiple sclerosis, and several other specific disorders, in comparison with existing treatments. Marijuana As Medicine? introduces readers to the active compounds in marijuana. These include the principal ingredient in Marinol, a legal medication. The authors also discuss the prospects for developing other drugs derived from marijuana's active ingredients. In addition to providing an up-to-date review of the science behind the medical marijuana debate, Mack and Joy also answer common questions about the legal status of marijuana, explaining the conflict between state and federal law regarding its medical use. Intended primarily as an aid to patients and caregivers, this book objectively presents critical information so that it can be used to make responsible health care decisions. Marijuana As Medicine? will also be a valuable resource for policymakers, health care providers, patient counselors, medical faculty and studentsâ€"in short, anyone who wants to learn more about this important issue.

Therapeutic Uses of Cannabis

Therapeutic Uses of Cannabis PDF Author: British Medical Association
Publisher: CRC Press
ISBN: 9789057023187
Category : Medical
Languages : en
Pages : 164

Get Book Here

Book Description
At the last Annual Representative Meeting of the British Medical Association a motion was passed that `certain additional cannabinoids should be legalized for wider medicinal use.'' This report supports this landmark statement by reviewing the scientific evidence for the therapeutic use of cannabinoids and sets the agenda for change. It will be welcomed by those who believe that cannabinoids can be used in medical treatment. The report discusses in a clear and readable form the use and adverse effects of the drug for nausea, multiple sclerosis, pain, epilepsy, glaucoma, and asthma.

Cannabis in Medicine

Cannabis in Medicine PDF Author: Kenneth Finn
Publisher: Springer Nature
ISBN: 3030459683
Category : Medical
Languages : en
Pages : 571

Get Book Here

Book Description
Legalization of marijuana is becoming increasingly prominent in the United States and around the world. While there is some discussion of the relationship between marijuana and overall health, a comprehensive resource that outlines the medical literature for several organ systems, as well as non-medical societal effects, has yet to be seen. While all physicians strive to practice evidence-based medicine, many clinicians aren't aware of the facts surrounding cannabis and are guided by public opinion. This first of its kind book is a comprehensive compilation of multiple facets of cannabis recommendation, use and effects from a variety of different perspectives. Comprised of chapters dedicated to separate fields of medicine, this evidence-based guide outlines the current data, or lack thereof, as well as the need for further study. The book begins with a general overview of the neurobiology and pharmacology of THC and hemp. It then delves into various medical concerns that plague specific disciplines of medicine such as psychiatry, cardiology, gastrointestinal and neurology, among others. The end of the book focuses on non-medical concerns such as public health and safety, driving impairment and legal implications. Comprised of case studies and meta-analyses, Cannabis in Medicine: An Evidence-Based Approach provides clinicians with with a concise, evidence-based guide to various health concerns related to the use of marijuana. By addressing non-medical concerns, this book is also a useful resource for professionals working in the public health and legal fields.

Marijuana and Medicine

Marijuana and Medicine PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309071550
Category : Medical
Languages : en
Pages : 288

Get Book Here

Book Description
The medical use of marijuana is surrounded by a cloud of social, political, and religious controversy, which obscures the facts that should be considered in the debate. This book summarizes what we know about marijuana from evidence-based medicineâ€"the harm it may do and the relief it may bring to patients. The book helps the reader understand not only what science has to say about medical marijuana but also the logic behind the scientific conclusions. Marijuana and Medicine addresses the science base and the therapeutic effects of marijuana use for medical conditions such as glaucoma and multiple sclerosis. It covers marijuana's mechanism of action, acute and chronic effects on health and behavior, potential adverse effects, efficacy of different delivery systems, analysis of the data about marijuana as a gateway drug, and the prospects for developing cannabinoid drugs. The book evaluates how well marijuana meets accepted standards for medicine and considers the conclusions of other blue-ribbon panels. Full of useful facts, this volume will be important to anyone interested in informed debate about the medical use of marijuana: advocates and opponents as well as policymakers, regulators, and health care providers.

Cannabis Pharmacy

Cannabis Pharmacy PDF Author: Michael Backes
Publisher: Black Dog & Leventhal
ISBN: 1603763341
Category : Health & Fitness
Languages : en
Pages : 475

Get Book Here

Book Description
In Cannabis Pharmacy, expert Michael Backes offers evidence-based information on using cannabis to treat an array of ailments and conditions. He provides information on how cannabis works with the body's own system, how best to prepare and administer it, and how to modify and control dosage. This newly revised edition is now completely up-to-date with the latest information on the body's encannabinoid system, which is now understood to control emotion, appetite, and memory, delivery and dosing of cannabis, including e-cigarette designs, additional varietals, and a new system for classification, as well as 21 additional ailments and conditions that can be treated with medical marijuana. There are currently more than 4.2 million medical cannabis patients in the United States, and there are 29 states plus the District of Columbia where medical cannabis is legal.

Ethnopharmacology

Ethnopharmacology PDF Author: Michael Heinrich
Publisher: John Wiley & Sons
ISBN: 1118930738
Category : Medical
Languages : en
Pages : 464

Get Book Here

Book Description
Ethnopharmacology is one of the world’s fastest-growing scientific disciplines encompassing a diverse range of subjects. It links natural sciences research on medicinal, aromatic and toxic plants with socio-cultural studies and has often been associated with the development of new drugs. The Editors of Ethnopharmacology have assembled an international team of renowned contributors to provide a critical synthesis of the substantial body of new knowledge and evidence on the subject that has emerged over the past decade. Divided into three parts, the book begins with an overview of the subject including a brief history, ethnopharmacological methods, the role of intellectual property protection, key analytical approaches, the role of ethnopharmacology in primary/secondary education and links to biodiversity and ecological research. Part two looks at ethnopharmacological contributions to modern therapeutics across a range of conditions including CNS disorders, cancer, bone and joint health and parasitic diseases. The final part is devoted to regional perspectives covering all continents, providing a state-of-the –art assessment of the status of ethnopharmacological research globally. A comprehensive, critical synthesis of the latest developments in ethnopharmacology. Includes a section devoted to ethnopharmacological contributions to modern therapeutics across a range of conditions. Contributions are from leading international experts in the field. This timely book will prove invaluable for researchers and students across a range of subjects including ethnopharmacology, ethnobotany, medicinal plant research and natural products research. Ethnopharmacology- A Reader is part of the ULLA Series in Pharmaceutical Sciences www.ullapharmsci.org

Pain Management and the Opioid Epidemic

Pain Management and the Opioid Epidemic PDF Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483

Get Book Here

Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.